Vivo Bio Tech Experiences Revision in Its Score Amid Strong Market Performance

Vivo Bio Tech, a microcap player in the Pharmaceuticals & Drugs industry, has recently made headlines as it reached a new 52-week high of Rs. 56.9. This milestone, achieved on January 7, 2025, marks a significant moment for the company, which has shown robust performance in the market. In today's trading session, Vivo Bio Tech outperformed its sector by 4.73%, continuing a positive trend with three consecutive days of gains, resulting in a remarkable 38.45% increase over this period. The stock opened with a notable gain of 11.09%, reflecting strong market activity. Additionally, it reached an intraday high of Rs. 56.9, showcasing a 14.93% increase during the day. Vivo Bio Tech's performance over the past year has also been commendable, with a return of 12.49%, surpassing the Sensex's performance of 8.81%. In light of these developments, MarketsMOJO has made an adjustment in its evaluation of Vivo Bio Tech, adding the stock to its list, indicating a shift in its score. The company is currently trading above its key moving averages, further highlighting its strong market position.